Iron

General Information

Brand: Ferrovin®
Active Ingredient: Iron Sucrose (Ferric Hydroxide Sucrose Complex)
Strength: 100 mg elemental iron / 5 ml (20 mg/ml)
Form: Concentrated solution for infusion
Administration: Intravenous (IV) only
Volume: 5 ml / ampoule
Packaging: 5 ampoules × 5 ml / box
Product Type: Intravenous Iron Supplement
Classification: Prescription medicine

Description

Ferrovin® is a prescription intravenous iron preparation containing iron sucrose, a ferric hydroxide sucrose complex designed to replenish iron stores in patients with iron deficiency anemia.

Iron is an essential mineral required for the production of hemoglobin, the protein responsible for transporting oxygen throughout the body. Insufficient iron levels can lead to anemia, fatigue, weakness, reduced physical endurance, and other symptoms associated with inadequate oxygen delivery.

Ferrovin® provides iron directly into the bloodstream, making it an option for patients who cannot tolerate oral iron supplements, have an inadequate response to oral treatment, or require intravenous iron replacement for an approved medical indication.

Each 5 ml ampoule contains 100 mg of elemental iron, supplied as an iron sucrose complex for professional intravenous administration.

Key Benefits

Effective Iron Replacement: Helps replenish depleted iron stores in patients with confirmed iron deficiency.

Supports Hemoglobin Production: Provides essential iron required for healthy red blood cell formation.

Intravenous Administration: Delivers iron directly into the bloodstream without relying on gastrointestinal absorption.

Alternative to Oral Iron: Suitable for selected patients who cannot tolerate or adequately absorb oral iron supplements.

Supports Anemia Management: Helps improve iron deficiency anemia when administered according to an appropriate treatment plan.

Convenient Ampoule Presentation: Each 5 ml ampoule contains 100 mg of elemental iron.

Professional Medical Therapy: Designed for controlled intravenous iron replacement under healthcare supervision.

Indications

• Treatment of laboratory-confirmed iron deficiency anemia when intravenous iron therapy is appropriate

• Iron deficiency in patients who cannot tolerate oral iron supplements

• Iron deficiency with inadequate response to oral iron treatment

• Iron deficiency associated with certain chronic medical conditions, according to approved indications

• Iron replacement in patients with impaired gastrointestinal iron absorption when clinically indicated

• Other approved indications according to the official prescribing information

Treatment Protocol

Dosage: Determined individually based on hemoglobin levels, iron studies, body weight, iron deficit, and clinical condition.

Administration: Intravenous (IV) infusion or slow IV injection only when permitted by the specific product instructions.

Preparation: Dilution, infusion concentration, and administration rate must follow the manufacturer's official prescribing information.

Treatment Frequency: Determined by the prescribing healthcare professional according to the patient's iron requirements and response.

Monitoring: Hemoglobin, ferritin, transferrin saturation, and clinical response should be evaluated during treatment.

Important: Ferrovin® must not be administered intramuscularly (IM) or subcutaneously (SC).

Precautions

• Prescription medicine – for administration by qualified healthcare professionals only.

• Intravenous iron can cause serious hypersensitivity reactions, including potentially life-threatening anaphylaxis.

• Administer only in a setting where appropriate emergency treatment and trained personnel are immediately available.

• Monitor patients during administration and for at least 30 minutes afterward, according to applicable product guidance.

• Do not use in patients with known hypersensitivity to iron sucrose or other product components.

• Avoid administration in patients with iron overload or anemia not caused by iron deficiency.

• Use caution in patients with active infections or significant liver disorders.

• Intravenous iron may cause hypotension, dizziness, nausea, headache, or injection-site reactions.

• Incorrect administration or leakage outside the vein may cause tissue irritation and potentially long-lasting skin discoloration.

• Use during pregnancy or breastfeeding requires individual medical assessment.

• Store according to the manufacturer's instructions and protect from inappropriate temperatures.

• Keep out of reach of children.

✨ Ferrovin® 100 mg / 5 ml – Professional intravenous iron sucrose therapy designed to replenish iron stores, support hemoglobin production, and manage iron deficiency anemia under medical supervision.